Form D · Biotechnology

Stratos Genomics Inc.

Seattle, WA · CIK 0001501187

Offering snapshot reported Jan 9, 2018 · SEC filing

Reported sold
$20.2M
Offering amount: $20.2M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 28, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 9, 2018Initial$20,156,451No comparison4SEC filing
Jun 7, 2016Amendment$4,520,502$552,211vs Sep 14, 201019SEC filing
Jun 17, 2015Amendment$29,999,975$19,999,976vs May 13, 20142SEC filing
May 13, 2014Initial$9,999,999No comparison1SEC filing
Sep 6, 2013Initial$2,000,000No comparison1SEC filing
Oct 16, 2012Initial$2,000,000No comparison1SEC filing
May 26, 2011Initial$210,720No comparison5SEC filing
Sep 14, 2010Initial$3,968,291No comparison19SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-302701

Source: Form D, filed Jan 9, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Heiner Dreismann Director
Lee Huntsman Director
Harold Kawaguchi Director
Mark Kokoris Director, Executive
Robert Mc Ruer Director
Bob Mc Ruer Director, Executive
Stephen Rose Director
Allan Stephan Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
World Trade Center East 2211 Elliott Avenue
Seattle, WA, 98121